Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure

FOLFIRINOX (FX) and gemcitabine (GEM) plus nab-paclitaxel (GnP) have been reported as effective regimens for unresectable advanced pancreatic cancer (APC). FX may be more effective but is also associated with more adverse events (AEs). Therefore, first-line treatment with FX followed by second-line...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Mita, Naoki, Iwashita, Takuji, Uemura, Shinya, Yoshida, Kensaku, Iwasa, Yuhei, Ando, Nobuhiro, Iwata, Keisuke, Okuno, Mitsuru, Mukai, Tsuyoshi, Shimizu, Masahito
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6616879/
https://ncbi.nlm.nih.gov/pubmed/31146420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8060761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados